Wednesday, October 27, 2010

Glaxo To Pay $750M For Manufacturing Fraud

GlaxoSmithKline has agreed to pay a $750 million fine to settle charges over numerous production problems - contaminated meds, mislabeled packaging and incorrect dosages - at a facility in Cidra, Puerto Rico. For more on the story go to Pharmalot,, FDA Law Blog, and the Wall Street Journal Law Blog.

No comments: